A lawsuit alleges the University of Chicago shared medical record data with Google that included information that should not have been, according to the New York Times.
Olaparib maintenance therapy stretched out progression-free survival, suggesting a need for germline BRCA1/2 mutation testing in pancreatic cancer patients.
In PLOS this week: statistical approach for integrating eQTL and GWAS data, microRNA signature distinguishes malignant and benign salivary gland tumors, and more.
Run by the daughter of a renowned genetic oncologist, CancerIQ is expanding and raising money as it rolls out its testing management and clinical decision support technology.
In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.
